Post-mastectomy radiotherapy in Denmark: From 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group

This paper describes the procedure of changing from 2D to 3D treatment planning guidelines for post-mastectomy radiotherapy in Denmark. The aim of introducing 3D planning for post-mastectomy radiotherapy was to optimize the target coverage and minimize the dose to the normal tissues. Initially, it was investigated whether it was possible to find a treatment technique alternative to the one recommended by the Danish Breast Cancer Cooperative Group (DBCG). A dosimetric comparison of a combined photon/electron 3-field technique (3F) and a partial wide tangent technique (PWT) was carried out on individual planning CT-scans from seven patients selected to represent a wide range of sizes and shapes of chest walls. The heart dose was lower for PWT than for 3F, however, for both techniques the dose was within the accepted constraints. The lung dose was higher but acceptable for six of the seven patients with PWT. The dose to the internal mammary nodes (IMN) was not satisfactory for five of the seven patients for 3F, whereas only two of the seven patients had a minimum dose lower than 95% of the prescribed dose with PWT. Finally, the dose to the contralateral breast was increased when using PWT compared to 3F. It was concluded that PWT was an appropriate choice of technique for future radiation treatment of post-mastectomy patients. A working group was formed and guidelines for 3D planning were developed during a series of workshops where radiation oncologists and physicists from all radiotherapy centres participated. This work also included a definition of the tissue structures needed to be outlined on the planning CT-scan. The work was initiated in 2003 and the guidelines were approved by the DBCG Radiotherapy Committee in 2006. The first of January 2007 the 3D guidelines had been fully implemented in five of the seven radiotherapy centres.

[1]  Dwight E Heron,et al.  Treatment techniques for 3D conformal radiation to breast and chest wall including the internal mammary chain. , 2007, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[2]  G. Svane,et al.  Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer , 2007, Acta oncologica.

[3]  P. Lambin,et al.  Quality Assurance in the EORTC Randomized Trial 22922/10925 Investigating the Role of Irradiation of the Internal Mammary and Medial Supraclavicular Lymph Node Chain Works , 2006, Strahlentherapie und Onkologie.

[4]  Lena Specht,et al.  Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Lena Specht,et al.  Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  C. Grau,et al.  Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Jinming Yu,et al.  The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. , 2001, International journal of radiation oncology, biology, physics.

[8]  M. Schipper,et al.  Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes. , 2004, International journal of radiation oncology, biology, physics.

[9]  R. Jagsi,et al.  Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based. , 2004, International journal of radiation oncology, biology, physics.

[10]  S. Tyldesley,et al.  Regional radiotherapy to axilla and supraclavicular fossa for adjuvant breast treatment: a comparison of four techniques. , 2004, International journal of radiation oncology, biology, physics.

[11]  Stine Korreman,et al.  Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  J. Battermann,et al.  Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  T. Fornander,et al.  Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose , 2001, Breast Cancer Research and Treatment.

[14]  A. E. Saarnak,et al.  Accuracy of internal mammary lymph node localization using lymphoscintigraphy, sonography and CT. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  M. Martel,et al.  Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. , 2002, International journal of radiation oncology, biology, physics.

[16]  M. Hinkelbein,et al.  Virtual simulation in patients with breast cancer. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  A. Grann,et al.  The relationship between radiation fields and regional lymph nodes in carcinoma of the breast. , 2001, International journal of radiation oncology, biology, physics.

[18]  L. Marks,et al.  Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: is a posterior axillary boost field necessary? , 2000, International journal of radiation oncology, biology, physics.

[19]  J. Overgaard,et al.  Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials , 1999, The Lancet.

[20]  B. Rasmussen,et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial , 1999, The Lancet.

[21]  J. Overgaard,et al.  Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. , 1999, Lancet.

[22]  B. Fowble,et al.  Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. , 1998, International journal of radiation oncology, biology, physics.

[23]  R K Ten Haken,et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.

[24]  I. Lax,et al.  Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[26]  A Ottolenghi,et al.  Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. , 1996, The British journal of radiology.

[27]  P. V. van Rijk,et al.  Optimizing radiotherapy of the internal mammary chain in breast carcinoma by scintigraphy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  L. Marks,et al.  To treat or not to treat the internal mammary nodes: a possible compromise. , 1994, International journal of radiation oncology, biology, physics.

[29]  H. Johansen,et al.  Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials. , 1988, Acta oncologica.